Lithium placental passage at delivery and neonatal outcomes: A retrospective observational study
Introduction Lithium is an effective mood stabilizer and is widely used as a first-line treatment for bipolar disorder in the perinatal period. Several guidelines have provided clinical advice on dosing strategy (dose reduction versus stop lithium) in the peripartum period to minimize the risk of...
Main Authors: | M.L. Imaz, M. Torra, D. Soy, K. Langorh, L. Garcia-Esteve, R. Martin-Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S092493382100540X/type/journal_article |
Similar Items
-
Lithium placental passage at delivery: an observational study
by: M.L. Imaz, et al.
Published: (2022-06-01) -
Infant exposure to lithium through breast milk
by: M.L. Imaz, et al.
Published: (2021-04-01) -
Clozapine placental passage at delivery: an update
by: M.L. Imaz, et al.
Published: (2022-06-01) -
Placental growth factor and placental perfusion
by: Sara Francesca Deiana, et al.
Published: (2014-10-01) -
Clinical Lactation Studies of Lithium: A Systematic Review
by: Maria Luisa Imaz, et al.
Published: (2019-09-01)